7-11 July 2019
EV75 - CEL 5: Dosimetry Challenges of New Nuclear Medicine Theranostic Agents (Stabin)Orlando IV 06:45 - 07:45 |
| The term theranostics is defined as the integration of a diagnostic test with a specific therapeutic intervention. The diagnostic test should identify patients who will likely respond to a particular therapy, fail to respond to a given drug or eventually exhibit adverse events. The therapeutic application seeks to treat a specific disease. This session will describe the criteria for selecting good theranostic radiopharmaceuticals, and provide an overview of several useful theranostic agents in use, or under consideration for use, in nuclear medicine therapy, with a focus on the radiation dosimetry aspects. |
